ArticleBritish journal of clinical pharmacology2026

Evaluation of the Medicines and Healthcare products Regulatory Agency's introduction of a risk-proportionate approach for clinical trials: An analysis of 4617 applications assessed between September 2023 and August 2024.

Andrea Manfrin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.